APA (7th ed.) Citation

Schroeder, J. R., Phillips, K. A., Epstein, D. H., Jobes, M. L., Furnari, M. A., Kennedy, A. P., . . . Preston, K. L. (2018). Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder. Psychopharmacology, 235(10), 2957. https://doi.org/10.1007/s00213-018-4986-5

Chicago Style (17th ed.) Citation

Schroeder, Jennifer R., Karran A. Phillips, David H. Epstein, Michelle L. Jobes, Melody A. Furnari, Ashley P. Kennedy, Markus Heilig, and Kenzie L. Preston. "Assessment of Pioglitazone and Proinflammatory Cytokines During Buprenorphine Taper in Patients with Opioid Use Disorder." Psychopharmacology 235, no. 10 (2018): 2957. https://doi.org/10.1007/s00213-018-4986-5.

MLA (9th ed.) Citation

Schroeder, Jennifer R., et al. "Assessment of Pioglitazone and Proinflammatory Cytokines During Buprenorphine Taper in Patients with Opioid Use Disorder." Psychopharmacology, vol. 235, no. 10, 2018, p. 2957, https://doi.org/10.1007/s00213-018-4986-5.